+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

AI in Neurology Market Size, Share & Trends Analysis Report by Application, Neurological Condition, Components, End Use, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 6241127
The global AI in neurology market size was estimated at USD 760.0 million in 2025 and is projected to reach USD 4.5 billion by 2033, growing at a CAGR of 24.9% from 2026 to 2033. The rising global prevalence of neurological disorders, along with the increasing focus on early diagnosis and precision medicine, are among the key factors driving market expansion.

In addition, growing adoption of remote monitoring solutions, coupled with supportive government initiatives and evolving regulatory frameworks, further drives the integration of AI technologies into neurological care, enhancing diagnostic accuracy, improving patient outcomes, and streamlining clinical workflows.

The section below outlines the key factors driving market growth, highlighting the rising prevalence of neurological disorders, the need for early diagnosis, and support from government and regulatory bodies.

Global AI in Neurology Market Report Segmentation

This report forecasts revenue growth and provides, at global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global AI in neurology market report based on component, application, neurological condition, end use, and region:

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software
  • AI-enabled Devices
  • Services

Application Outlook (Revenue, USD Million, 2021-2033)

  • Neuroimaging & Diagnostics
  • Clinical Decision Support Systems (CDSS)
  • Disease Progression Monitoring
  • Brain-Computer Interface (BCI) & Neurotechnology
  • Rehabilitation & Therapy Management
  • Drug Discovery & Development
  • Others

Neurological Condition Outlook (Revenue, USD Million, 2021-2033)

  • Stroke
  • Alzheimer’s Disease & Dementia
  • Parkinson’s Disease
  • Epilepsy
  • Multiple Sclerosis
  • Traumatic Brain Injury (TBI)
  • Brain Tumors
  • Others

End use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Neurology Centers
  • Research & Academic Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Application Segment
1.2.3. Neurological Condition Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. AI in Neurology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Case Study Insights
3.4. AI in Neurology Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.2. PESTEL Analysis
Chapter 4. AI in Neurology Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global AI in Neurology Market Component Movement Analysis
4.3. Global AI in Neurology Market Size & Trend Analysis, by Component, 2021-2033 (USD Million)
4.4. Software
4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.5. AI-enabled Devices
4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. AI in Neurology Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global AI in Neurology Market Application Movement Analysis
5.3. Global AI in Neurology Market Size & Trend Analysis, by Application, 2021-2033 (USD Million)
5.4. Neuroimaging & Diagnostics
5.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.5. Clinical Decision Support Systems (CDSS)
5.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.6. Disease Progression Monitoring
5.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.7. Drug Discovery & Development
5.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.8. Brain-Computer Interface (BCI) & Neurotechnology
5.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.9. Rehabilitation & Therapy Management
5.9.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.10. Others
5.10.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. AI in Neurology Market: Neurological Condition Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global AI in Neurology Market: Neurological Condition Movement Analysis
6.3. Global AI in Neurology Market Size & Trend Analysis, by Neurological Condition, 2021-2033 (USD Million)
6.4. Stroke
6.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.5. Alzheimer’s Disease & Dementia
6.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.6. Parkinson’s Disease
6.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.7. Epilepsy
6.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.8. Multiple Sclerosis
6.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.9. Traumatic Brain Injury (TBI)
6.9.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.10. Brain Tumors
6.10.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.11. Others
6.11.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. AI in Neurology Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global AI in Neurology Market: End Use Movement Analysis
7.3. Global AI in Neurology Market Size & Trend Analysis, by End Use, 2021-2033 (USD Million)
7.4. Hospitals & Clinics
7.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.5. Neurology Centers
7.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.6. Research & Academic Institutions
7.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.7. Pharmaceutical & Biotechnology Companies
7.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.8. Others
7.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. AI in Neurology Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
8.4. North America
8.4.1. U.S.
8.4.2. Canada
8.4.3. Mexico
8.5. Europe
8.5.1. UK
8.5.2. Germany
8.5.3. France
8.5.4. Italy
8.5.5. Spain
8.5.6. Norway
8.5.7. Sweden
8.5.8. Denmark
8.6. Asia-Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Australia
8.6.5. South Korea
8.6.6. Thailand
8.7. Latin America
8.7.1. Brazil
8.7.2. Argentina
8.8. MEA
8.8.1. South Africa
8.8.2. Saudi Arabia
8.8.3. UAE
8.8.4. Kuwait
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. GE Healthcare
9.4.2. Cortechs.ai
9.4.3. Viz.ai
9.4.4. RapidAI (trademarks of iSchemaView, Inc)
9.4.5. Aidoc
9.4.6. Brainomix
9.4.7. Avicenna.AI
9.4.8. Natus
9.4.9. Hyperfine
9.4.10. PERSYST DEVELOPMENT LLC
9.4.11. Ceribell, Inc.
9.4.12. Empatica Inc.
9.4.13. Koninklijke Philips N.V.
9.4.14. Siemens Healthiness
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America AI in neurology market, by region, 2021-2033 (USD Million)
Table 4 North America AI in neurology market, by component, 2021-2033 (USD Million)
Table 5 North America AI in neurology market, by application, 2021-2033 (USD Million)
Table 6 North America AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 7 North America AI in neurology market, by end use, 2021-2033 (USD Million)
Table 8 U.S. AI in neurology market, by component, 2021-2033 (USD Million)
Table 9 U.S. AI in neurology market, by application, 2021-2033 (USD Million)
Table 10 U.S. AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 11 U.S. AI in neurology market, by end use, 2021-2033 (USD Million)
Table 12 Canada AI in neurology market, by component, 2021-2033 (USD Million)
Table 13 Canada AI in neurology market, by application, 2021-2033 (USD Million)
Table 14 Canada AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 15 Canada AI in neurology market, by end use, 2021-2033 (USD Million)
Table 16 Mexico AI in neurology market, by component, 2021-2033 (USD Million)
Table 17 Mexico AI in neurology market, by application, 2021-2033 (USD Million)
Table 18 Mexico AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 19 Mexico AI in neurology market, by end use, 2021-2033 (USD Million)
Table 20 Europe AI in neurology market, by region, 2021-2033 (USD Million)
Table 21 Europe AI in neurology market, by component, 2021-2033 (USD Million)
Table 22 Europe AI in neurology market, by application, 2021-2033 (USD Million)
Table 23 Europe AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 24 Europe AI in neurology market, by end use, 2021-2033 (USD Million)
Table 25 Germany AI in neurology market, by component, 2021-2033 (USD Million)
Table 26 Germany AI in neurology market, by application, 2021-2033 (USD Million)
Table 27 Germany AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 28 Germany AI in neurology market, by end use, 2021-2033 (USD Million)
Table 29 France AI in neurology market, by component, 2021-2033 (USD Million)
Table 30 France AI in neurology market, by application, 2021-2033 (USD Million)
Table 31 France AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 32 France AI in neurology market, by end use, 2021-2033 (USD Million)
Table 33 UK AI in neurology market, by component, 2021-2033 (USD Million)
Table 34 UK AI in neurology market, by application, 2021-2033 (USD Million)
Table 35 UK AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 36 UK AI in neurology market, by end use, 2021-2033 (USD Million)
Table 37 Italy AI in neurology market, by component, 2021-2033 (USD Million)
Table 38 Italy AI in neurology market, by application, 2021-2033 (USD Million)
Table 39 Italy AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 40 Italy AI in neurology market, by end use, 2021-2033 (USD Million)
Table 41 Spain AI in neurology market, by component, 2021-2033 (USD Million)
Table 42 Spain AI in neurology market, by application, 2021-2033 (USD Million)
Table 43 Spain AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 44 Spain AI in neurology market, by end use, 2021-2033 (USD Million)
Table 45 Denmark AI in neurology market, by component, 2021-2033 (USD Million)
Table 46 Denmark AI in neurology market, by application, 2021-2033 (USD Million)
Table 47 Denmark AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 48 Denmark AI in neurology market, by end use, 2021-2033 (USD Million)
Table 49 Sweden AI in neurology market, by component, 2021-2033 (USD Million)
Table 50 Sweden AI in neurology market, by application, 2021-2033 (USD Million)
Table 51 Sweden AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 52 Sweden AI in neurology market, by end use, 2021-2033 (USD Million)
Table 53 Norway AI in neurology market, by component, 2021-2033 (USD Million)
Table 54 Norway AI in neurology market, by application, 2021-2033 (USD Million)
Table 55 Norway AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 56 Norway AI in neurology market, by end use, 2021-2033 (USD Million)
Table 57 Asia-Pacific AI in neurology market, by region, 2021-2033 (USD Million)
Table 58 Asia-Pacific AI in neurology market, by component, 2021-2033 (USD Million)
Table 59 Asia-Pacific AI in neurology market, by application, 2021-2033 (USD Million)
Table 60 Asia-Pacific AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 61 Asia-Pacific AI in neurology market, by end use, 2021-2033 (USD Million)
Table 62 China AI in neurology market, by component, 2021-2033 (USD Million)
Table 63 China AI in neurology market, by application, 2021-2033 (USD Million)
Table 64 China AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 65 China AI in neurology market, by end use, 2021-2033 (USD Million)
Table 66 Japan AI in neurology market, by component, 2021-2033 (USD Million)
Table 67 Japan AI in neurology market, by application, 2021-2033 (USD Million)
Table 68 Japan AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 69 Japan AI in neurology market, by end use, 2021-2033 (USD Million)
Table 70 India AI in neurology market, by component, 2021-2033 (USD Million)
Table 71 India AI in neurology market, by application, 2021-2033 (USD Million)
Table 72 India AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 73 India AI in neurology market, by end use, 2021-2033 (USD Million)
Table 74 South Korea AI in neurology market, by component, 2021-2033 (USD Million)
Table 75 South Korea AI in neurology market, by application, 2021-2033 (USD Million)
Table 76 South Korea AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 77 South Korea AI in neurology market, by end use, 2021-2033 (USD Million)
Table 78 Australia AI in neurology market, by component, 2021-2033 (USD Million)
Table 79 Australia AI in neurology market, by application, 2021-2033 (USD Million)
Table 80 Australia AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 81 Australia AI in neurology market, by end use, 2021-2033 (USD Million)
Table 82 Thailand AI in neurology market, by component, 2021-2033 (USD Million)
Table 83 Thailand AI in neurology market, by application, 2021-2033 (USD Million)
Table 84 Thailand AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 85 Thailand AI in neurology market, by end use, 2021-2033 (USD Million)
Table 86 Latin America AI in neurology market, by region, 2021-2033 (USD Million)
Table 87 Latin America AI in neurology market, by component, 2021-2033 (USD Million)
Table 88 Latin America AI in neurology market, by application, 2021-2033 (USD Million)
Table 89 Latin America AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 90 Latin America AI in neurology market, by end use, 2021-2033 (USD Million)
Table 91 Brazil AI in neurology market, by component, 2021-2033 (USD Million)
Table 92 Brazil AI in neurology market, by application, 2021-2033 (USD Million)
Table 93 Brazil AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 94 Brazil AI in neurology market, by end use, 2021-2033 (USD Million)
Table 95 Argentina AI in neurology market, by region, 2021-2033 (USD Million)
Table 96 Argentina AI in neurology market, by component, 2021-2033 (USD Million)
Table 97 Argentina AI in neurology market, by application, 2021-2033 (USD Million)
Table 98 Argentina AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 99 Argentina AI in neurology market, by end use, 2021-2033 (USD Million)
Table 100 MEA AI in neurology market, by region, 2021-2033 (USD Million)
Table 101 MEA AI in neurology market, by component, 2021-2033 (USD Million)
Table 102 MEA AI in neurology market, by application, 2021-2033 (USD Million)
Table 103 MEA AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 104 MEA AI in neurology market, by end use, 2021-2033 (USD Million)
Table 105 South Africa AI in neurology market, by component, 2021-2033 (USD Million)
Table 106 South Africa AI in neurology market, by application, 2021-2033 (USD Million)
Table 107 South Africa AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 108 South Africa AI in neurology market, by end use, 2021-2033 (USD Million)
Table 109 Saudi Arabia AI in neurology market, by component, 2021-2033 (USD Million)
Table 110 Saudi Arabia AI in neurology market, by application, 2021-2033 (USD Million)
Table 111 Saudi Arabia AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 112 Saudi Arabia AI in neurology market, by end use, 2021-2033 (USD Million)
Table 113 UAE AI in neurology market, by component, 2021-2033 (USD Million)
Table 114 UAE AI in neurology market, by application, 2021-2033 (USD Million)
Table 115 UAE AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 116 UAE AI in neurology market, by end use, 2021-2033 (USD Million)
Table 117 Kuwait AI in neurology market, by component, 2021-2033 (USD Million)
Table 118 Kuwait AI in neurology market, by application, 2021-2033 (USD Million)
Table 119 Kuwait AI in neurology market, by neurological condition, 2021-2033 (USD Million)
Table 120 Kuwait AI in neurology market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 AI in neurology market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Commodity flow analysis
Figure 5 Parent market analysis
Figure 6 AI in neurology market snapshot
Figure 7 AI in neurology market segment snapshot (part 1)
Figure 8 AI in neurology market segment snapshot (part 2)
Figure 9 AI in neurology market competitive landscape snapshot
Figure 10 Market research process
Figure 11 Parent market outlook (USD Billion) (2025)
Figure 12 AI in neurology market dynamics
Figure 13 AI in neurology market: Porter’s five forces analysis
Figure 14 AI in neurology market: PESTLE analysis
Figure 15 AI in neurology market, component outlook key takeaways (USD million)
Figure 16 AI in neurology market: component movement analysis, 2025 & 2033 (USD Million)
Figure 17 Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 18 AI-enabled devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 AI in neurology market, application outlook key takeaways (USD Million)
Figure 21 AI in neurology market: application movement analysis, 2025 & 2033 (USD Million)
Figure 22 Neuroimaging & diagnostics market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Clinical decision support systems (CDSS) market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Disease Progression Monitoring market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Drug discovery & development market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Brain-computer interface (BCI) & neurotechnology market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Rehabilitation & therapy management market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 AI in neurology market, neurological condition outlook key takeaways (USD Million)
Figure 30 AI in neurology market: neurological condition movement analysis, 2025 & 2033 (USD Million)
Figure 31 Stroke market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Alzheimer’s disease & dementia market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Parkinson’s disease market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Epilepsy market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Multiple Sclerosis market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Traumatic brain injury (TBI) market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Brain tumors market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 AI in neurology market, end use outlook key takeaways (USD Million)
Figure 40 AI in neurology market: end use analysis, 2025 & 2033 (USD Million)
Figure 41 Hospitals & clinics market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Neurology centers market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Research & academic institutions market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 Artificial intelligence in Neurology Market: Regional outlook
Figure 48 North America AI in neurology market, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 U.S AI in neurology market, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Canada AI in neurology market, 2021-2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 Mexico AI in neurology market, 2021-2033 (USD Million)
Figure 55 Europe AI in neurology market, 2021-2033 (USD Million)
Figure 56 Key country dynamics
Figure 57 UK AI in neurology market, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 Germany AI in neurology market, 2021-2033 (USD Million)
Figure 60 Key country dynamics
Figure 61 France AI in neurology market, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 Italy AI in neurology market, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 Spain AI in neurology market, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 Sweden AI in neurology market, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Denmark AI in neurology market, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 Norway AI in neurology market, 2021-2033 (USD Million)
Figure 72 Asia-Pacific AI in neurology market, 2021-2033 (USD Million)
Figure 73 Key country dynamics
Figure 74 Japan AI in neurology market, 2021-2033 (USD Million)
Figure 75 Key country dynamics
Figure 76 China AI in neurology market, 2021-2033 (USD Million)
Figure 77 Key country dynamics
Figure 78 India AI in neurology market, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Australia AI in neurology market, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Thailand AI in neurology market, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 South Korea AI in neurology market, 2021-2033 (USD Million)
Figure 85 Latin America AI in neurology market, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Brazil AI in neurology market, 2021-2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 Argentina AI in neurology market, 2021-2033 (USD Million)
Figure 90 MEA AI in neurology market, 2021-2033 (USD Million)
Figure 91 Key country dynamics
Figure 92 South Africa AI in neurology market, 2021-2033 (USD Million)
Figure 93 Key country dynamics
Figure 94 Saudi Arabia AI in neurology market, 2021-2033 (USD Million)
Figure 95 Key country dynamics
Figure 96 UAE AI in neurology market, 2021-2033 (USD Million)
Figure 97 Key country dynamics
Figure 98 Kuwait AI in neurology market, 2021-2033 (USD Million)
Figure 99 Company Categorization
Figure 100 Company market position/share analysis, 2025
Figure 101 Strategic Framework

Companies Mentioned

  • Cortechs.ai
  • Viz.ai
  • RapidAI (trademarks of iSchemaView, Inc)
  • Aidoc
  • Brainomix
  • Avicenna.AI
  • Natus
  • Hyperfine
  • PERSYST DEVELOPMENT LLC
  • Ceribell, Inc.
  • Empatica Inc.
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Siemens Healthiness

Table Information